ETES Modules are custom-designed fusion molecules engineered to harness the body's endogenous T-cell responses without disrupting native immune signaling pathways. At Alfa Cytology, we specialize in designing and optimizing these ETES modules to ensure that T-cells can effectively target and eliminate tumor cells, enhancing cancer treatment precision and safety.
Unlike traditional synthetic receptors that disrupt native T-cell receptor (TCR) signaling, ETES modules maintain physiological immune processes. By integrating carefully selected antigen-binding extracellular domains with intracellular signaling motifs that mirror natural T-cell co-receptor function, ETES ensures robust yet controlled T-cell activation directly triggered by the presence of cancer-specific antigens.


Antigen Binding Domain
Engineered extracellular domains tailored specifically for recognition of distinct cancer antigens.
TCR Binding Domain
Designed for precise and effective engagement of the native T-cell receptor (TCR) complex on T-cells, ensuring potent T-cell activation.
Co-Receptor Domain
Custom intracellular domains that modulate T-cell responses to improve activation specificity and persistence.
Single-Antigen ETES Modules
Designed to precisely target a specific tumor-associated antigen (TAA), these modules enable focused and highly efficient therapeutic responses, ideal for tumors characterized by consistent antigen expression.
Multi-Antigen ETES Modules
Engineered to simultaneously recognize multiple tumor-associated antigens, these modules effectively address tumor heterogeneity and prevent tumor escape due to antigen loss, improving therapeutic efficacy in more complex tumor environments.
Conditional Activation ETES Modules
These modules incorporate inducible or condition-dependent signaling motifs, activating only in the presence of specific tumor microenvironment signals. This design significantly enhances safety and specificity, reducing potential off-target effects and immune toxicity.
Affinity-Optimized ETES Modules
These ETES modules feature engineered extracellular domains with optimized binding affinities to tumor antigens, enhancing selective targeting, therapeutic potency, and reducing off-target immune activation.
At Alfa Cytology, our approach begins with detailed profiling of your targeted tumor antigen and the surrounding immune microenvironment. Our expert bioengineering team subsequently designs ETES™ modules, optimizing both the extracellular antigen-binding domains and the intracellular activation sequences.

Antigen Profiling and Selection
Extensive tumor-specific antigen characterization is conducted using advanced bioinformatics and laboratory-based techniques. Optimal targets are identified based on their specificity, expression profiles, and potential for minimal cross-reactivity.

Computational Design and Optimization
State-of-the-art computational modeling is applied to optimize ETES™ constructs. Techniques including codon optimization, molecular dynamics simulations, and affinity maturation ensure maximal binding affinity, stability, and functionality prior to empirical synthesis.

ETES Construct Synthesis
Advanced gene editing technologies, such as CRISPR/Cas9, alongside precision synthetic biology methodologies, are employed in assembling high-quality ETES™ constructs. This step ensures optimal expression and functional integrity within engineered T-cells.

Functional Validation
Rigorous in vitro validation protocols are implemented to confirm ETES™ construct performance. Assays including binding affinity tests, T-cell activation profiling, cytokine secretion quantification, and specificity evaluations ensure comprehensive functional validation.
|
|||
|
Looking for precise and targeted ETES modules to enhance your cancer research? Let Alfa Cytology help you design tailored solutions for your preclinical studies. With our expertise in custom module development and testing, we can support your project's success every step of the way.Feel free to contact us to discuss your specific needs or explore collaboration opportunities.
For research use only.